EP Patent

EP3915542A1 — Methods and formulations for transdermal administration

Assigned to Dyve Biosciences Inc · Expires 2021-12-01 · 4y expired

What this patent protects

Improved formulations for topical treatment that ensure at least localized transdermal systemic delivery of an active agent through skin, nails or hair follicles are disclosed.

USPTO Abstract

Improved formulations for topical treatment that ensure at least localized transdermal systemic delivery of an active agent through skin, nails or hair follicles are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP3915542A1
Jurisdiction
EP
Classification
—
Expires
2021-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Dyve Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.